Company Overview and News

11
Simple Green, Midstream Red

2018-10-14 seekingalpha
Midstream sold off along with most things this week, but as a whole did slightly better than the broad stock market, outperforming for a second straight week. MLPs were the best-performing group in midstream, benefiting from their renewed obscurity more than a flight to safety. Just like when the S&P 500 is going up, the market seems pre-occupied with itself, rather than paying much attention to midstream and certainly not MLPs.
KEYUF GPRE COG AR NAP AM GNE NNA KMI WMB GPP GNE AMGP KMR PBA FGP CVB KMRFZ GEL

3
New Strong Sell Stocks for October 11th

2018-10-11 zacks - 1
Cabot Oil & Gas Corporation (COG - Free Report) is an independent oil and gas company. The Zacks Consensus Estimate for its current year earnings has been revised 0.9% downward over the last 30 days.
CBSH CBSHP PPG LBRT COG CC FNV CBCB SGH

 
COG / Cabot Oil & Gas Corp. / Capital World Investors - SC 13G/A (Passive Investment)

2018-10-10 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Cabot Oil & Gas Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 127097103 (CUSIP Number) September 28, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant
COG

1
COG / Cabot Oil & Gas Corp. / Capital World Investors - SC 13G/A (Passive Investment)

2018-10-10 sec.gov - 1
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Cabot Oil & Gas Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 127097103 (CUSIP Number) September 28, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant
COG

6
Oil Prices Rise On Iran, Hurricane Outages

2018-10-10 oilprice
Tom majored in International Business at Amsterdam’s Higher School of Economics, he is now working as news editor for Oilprice.com.
FP E BLT XOM BHPBF COG NYTAB TOT BP BHP BBL BHP BHPLF EQNR

 
COG / Cabot Oil & Gas Corp. 8-K (Current Report)

2018-10-10 sec.gov
Document UNITED STATES
COG

 
Cabot Oil & Gas: It's About Time

2018-10-08 seekingalpha
These days, investors apparently don't believe a new pipeline will go in-service until it actually goes in-service.
WPZ COG

48
Natural Gas Jumps to 8-Month High on Low Storage Levels

2018-10-08 zacks - 1
The U.S. Energy Department's weekly inventory release showed a bigger-than-expected increase in natural gas supplies. Despite the stockpile surge, natural gas prices rallied to their highest levels since January as inventories remain significantly below their five-year average ahead of the upcoming winter.
ECR CKRGZ FCN CNX.WI CHKVP CRK COG CVS CHKDH CHKVZ CHKDG CHKWZ CHKDJ CHKDP CHK CHK.WI GPOR

57
E&P 'Middle Of The Road Club' (Permian Edition) #18-1

2018-10-08 seekingalpha - 5
E&P companies that are neither top institutional favorites nor companies I would classify in my Bottom of the Barrel Club may have wide appeal to investors.
GIS XOM PXD QEP AR CRZO WMB XOG NBL WLL PDCE SRCI SM CTLR NFX RRS WPX ESTE RGRLF RRC WTI CLR OXY AEUA HAL APC APA WPXP DVN CXO PE RRL COP ROSEU RSPP REI AMR EGN JAG ROSE CDEV D COG EOG RGRYY HP CVX LPI HK FANG

23
What Drove Brent Above $85?

2018-10-02 oilprice
Tom majored in International Business at Amsterdam’s Higher School of Economics, he is now working as news editor for Oilprice.com.
E RDS.B RDS.A D XOM COG RRL RDSB RDSA RRS RGRLF RRC RGRYY CVX RYDBF SWN RYDAF EQNR

29
E&P 'Middle Of The Road Club' (Non-Permian Edition) #18-1

2018-10-01 seekingalpha - 2
E&P companies that are neither top institutional favorites nor companies I would classify in my Bottom of the Barrel Club may have wide appeal to investors.
APC APA WPXP DVN QEP PE CXO EPE RRL AR CRZO ROSEU REI GPOR JNEEP AMR MUR.WI MUR JAG ROSE XOG JGPK NBL WLL PDCE SRCI SM CTLR COG BCEI NFX RRS JONE WPX RGRLF EOG RRC OAS RGRYY LPI MRO CLR ROAN AEUA FANG

3
Cabot Will Profit (More) As A Low-Cost Leader

2018-09-28 seekingalpha
Cabot Oil & Gas expects improved gas pricing and profitability, including a five-fold earning per share increase in 2019 due to both industry-wide and company-specific factors.
RRC EQT RGRYY CNX.WI XOM COG RRL RRS AR RGRLF

41
Natural Gas Storage Deficit to 5-Year Average Widens Further

2018-09-28 zacks - 1
The U.S. Energy Department's weekly inventory release showed a smaller-than-expected increase in natural gas supplies. The headline beat, which further widened the storage deficit ahead of the upcoming winter, helped the fuel to remain above the psychologically important $3 level.
ECR CKRGZ CQP CNX.WI LNG CHKVP CRK COG CHKDH CHKVZ CHKDG CHKWZ CHKDJ CHKDP CHK CHK.WI GPOR GPN

175
The Zacks Analyst Blog Highlights: Cabot Oil, Chesapeake, Comstock, Southwestern and SilverBow

2018-09-25 zacks - 2
Chicago, IL –September 25, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Cabot Oil & Gas Corp. (COG - Free Report) , Chesapeake Energy Corp. (CHK - Free Report) , Comstock Resources, Inc. (CRK - Free Report) , Southwestern Energy Co.
CKRGZ CQP LNG CHKVP RAD CRK COG SBOW CHKDH CHKVZ CHKDG CHKWZ CHKDJ CHKDP CHK CHK.WI TITN

40
Natural Gas Posts Sharp Weekly Gain on Hefty Storage Deficit

2018-09-24 zacks
The U.S. Energy Department's weekly inventory release showed a larger-than-expected increase in natural gas supplies. Despite the headline miss, a hefty storage deficit ahead of the upcoming winter pointed to tightening fundamentals and spurred the fuel’s price, which gained about 7.6% for the week.
ECR CKRGZ CQP LNG CHKVP CRK RDN COG SBOW CHKDH CHKVZ CHKDG CHKWZ CHKDJ CHKDP CHK CHK.WI GPOR

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to COG / Cabot Oil & Gas Corp. on message board site Silicon Investor.

Cognex - Looks undervalued... Cognex - Looks undervalued... Cognex - Looks undervalued... Cognizant Technology Solutions Inc (CTSH) Cognizant Technology Solutions Inc (CTSH) Cognizant Technology Solutions Inc (CTSH)
cogitore resources woo tsx.v cogitore resources woo tsx.v cogitore resources woo tsx.v Comtech Group, Inc. (COGO) Comtech Group, Inc. (COGO) Comtech Group, Inc. (COGO)
OSI Pharmaceuticals (OSIP) - formerly Oncogene OSI Pharmaceuticals (OSIP) - formerly Oncogene OSI Pharmaceuticals (OSIP) - formerly Oncogene GlycoGenesys GLGS (formerly SafeScience SAFS) GlycoGenesys GLGS (formerly SafeScience SAFS) GlycoGenesys GLGS (formerly SafeScience SAFS)
Fonix:Voice Recognition Product (FONX) Fonix:Voice Recognition Product (FONX) Fonix:Voice Recognition Product (FONX) Cognigen:CGNW Cognigen:CGNW Cognigen:CGNW
Cogent Inc (COGT) Cogent Inc (COGT) Cogent Inc (COGT) Cognicase (COGI, T.COG) - Integrated IT Solutions Cognicase (COGI, T.COG) - Integrated IT Solutions Cognicase (COGI, T.COG) - Integrated IT Solutions
CUSIP: 127097103